SlideShare a Scribd company logo
1 of 14
REGULATORY AFFAIR
Submitted By: Prachi Pandey, Rahul Pal
Department of Pharmaceuitcs, NIMS Institute of Pharmacy, NIMS
University Jhaipur, Rajasthan India.
1st Year, Ist Sem.
CONTENTS
 Definition
 History
 Informed Consent Guidelines
 The Process of Consent
 The Plan of Consent Process
 Element of ICF
 Components of ICF
 A process by which a subject voluntarily confirms his or her willingness to
participate in a particular trail, after having been informed of all aspects of the
trail that are relevant to the subject’s decision to participate
 Inform consent is documented by means of a written, signed and dated
informed consent form.
 The goal of the informed consent process is to provide people with sufficient
information so that they can make informed choices about whether to begin or
continue participation in clinical research.
Declaration of
helsinki
 The World Medical Association (WMA) has
developed the Declaration of Helsinki as a
statement of ethical principles for medical
research involving human subjects, including
research on identifiable human material and
data.
Informed consent
guidelines
 ICMR (Indian Council of Medical
Research)
“Ethical Guidelines for Biomedical
Research on Human use”
Published in 2000 and revised in 2006
 ICH
ICH Guidelines E6 section 4.8 under
GCP
(Good Clinical Practice)
Information provision and sharing by research team
Discussion and interaction between research and potential
participation
True understanding
Acceptance or rejection of participant
Agreement to
participate
Follow up
End of
agreement
The Process of Consent
Continue Continue the process of consent throughout the study.
Ensure Ensure the subject or LAR has sufficient understanding.
Ensure Ensure that the subject or Legally Authorized Representative is competent.
Include Include family members in the process as warranted.
Involve Involve multiple health care personnel as necessary.
Choose Choose the right environment and location to obtain consent.
Subject or Legally
Acceptable
Representative
(LAR)
Person conducting
review of consent
Impartial witness
Elements of
Informed
Consent Form
1. Essential element:
 Purpose
 Risks
 Benefits
 Confidentiality
 Compensation
 Contact information
 Voluntary participation
Elements of ICF
Statement that
will be told of
new findings.
Approximate
number of
subjects in
study
Statement that
there may be
risks which are
unforeseeable.
Additional costs
to subjects.
Withdrawal
criteria
Additional
elements
Components of ICF
(According to ICMR guidelines, 2006)
 Important Information about the Research Study.
 What is the study about and why are we doing it?
 Benefits of taking part in the study.
 Possible risks that might result from being in the study.
 Certificate of Confidentiality
 What will happen to the information collected after study period is over.
 Compensation for being part of the study
 Possible expenditure to a subject to be part of study.
 Who can profit from study results.
 Choices to a subject if they don’t wish to take part in the study.
 Voluntariness
 Contact information of subject
 Contact information of study team.
 Consent : Name , Signature and Date
 Parent or LAR : Name , Signature and Date
REGULATORY AFFAIR Involve Informed Concent Process and Procedure.pptx

More Related Content

What's hot

Periodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsPeriodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsTGA Australia
 
New drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfNew drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfcrazyboy92
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union ShantanuThakre3
 
Clinical data management
Clinical data managementClinical data management
Clinical data managementDibakarGhosh15
 
Monitoring plan and basic monitoring visits: everything that a cra needs to know
Monitoring plan and basic monitoring visits: everything that a cra needs to knowMonitoring plan and basic monitoring visits: everything that a cra needs to know
Monitoring plan and basic monitoring visits: everything that a cra needs to knowTrialJoin
 
An Introduction to the Pharmacovigilance System Master File
An Introduction to the Pharmacovigilance System Master FileAn Introduction to the Pharmacovigilance System Master File
An Introduction to the Pharmacovigilance System Master FileTransPerfect Trial Interactive
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical TrialSandeepkarki13
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Aakashdeep Raval
 
Site & investigator selection
Site & investigator selectionSite & investigator selection
Site & investigator selectionMukesh Jaiswal
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trialswati2084
 
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptxREGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptxPrachi Pandey
 
Investigator’s meeting
Investigator’s meetingInvestigator’s meeting
Investigator’s meetingBageshri Mestry
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCERamakrishna K
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilSwapnil Patil
 

What's hot (20)

Periodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questionsPeriodic Safety Update Reports: Some commonly asked questions
Periodic Safety Update Reports: Some commonly asked questions
 
Ich e6(r1)
Ich e6(r1)Ich e6(r1)
Ich e6(r1)
 
New drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdfNew drugs and clinical trial rules 2019.pdf
New drugs and clinical trial rules 2019.pdf
 
Clinical Research Regulation in European Union
Clinical Research Regulation in European Union Clinical Research Regulation in European Union
Clinical Research Regulation in European Union
 
Clinical data management
Clinical data managementClinical data management
Clinical data management
 
Monitoring plan and basic monitoring visits: everything that a cra needs to know
Monitoring plan and basic monitoring visits: everything that a cra needs to knowMonitoring plan and basic monitoring visits: everything that a cra needs to know
Monitoring plan and basic monitoring visits: everything that a cra needs to know
 
An Introduction to the Pharmacovigilance System Master File
An Introduction to the Pharmacovigilance System Master FileAn Introduction to the Pharmacovigilance System Master File
An Introduction to the Pharmacovigilance System Master File
 
Presentation on Clinical Trial
Presentation on Clinical TrialPresentation on Clinical Trial
Presentation on Clinical Trial
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
 
New ct rule 2019
New ct rule 2019New ct rule 2019
New ct rule 2019
 
Site & investigator selection
Site & investigator selectionSite & investigator selection
Site & investigator selection
 
Multicenter trial
Multicenter trialMulticenter trial
Multicenter trial
 
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptxREGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
REGULATORY AFFAIR (Informed Concent Process and Procedure)).pptx
 
Investigator’s meeting
Investigator’s meetingInvestigator’s meeting
Investigator’s meeting
 
Audits & Inspections in Clinical Research
Audits & Inspections in Clinical ResearchAudits & Inspections in Clinical Research
Audits & Inspections in Clinical Research
 
Current Landscape for Safety Reporting in Clinical Trials
Current Landscape for Safety Reporting in Clinical TrialsCurrent Landscape for Safety Reporting in Clinical Trials
Current Landscape for Safety Reporting in Clinical Trials
 
DSUR
DSURDSUR
DSUR
 
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCEAN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
AN OVERVIEW AND IMPORTANCE OF PHARMACOVIGILANCE
 
EU Clinical Trials Regulation.. Summarised
EU Clinical Trials Regulation.. SummarisedEU Clinical Trials Regulation.. Summarised
EU Clinical Trials Regulation.. Summarised
 
Good Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patilGood Clinical Practice By: Swapnil L. patil
Good Clinical Practice By: Swapnil L. patil
 

Similar to REGULATORY AFFAIR Involve Informed Concent Process and Procedure.pptx

informed consent process and procedure .pptx
informed consent process and procedure .pptxinformed consent process and procedure .pptx
informed consent process and procedure .pptxAbdulNaim14
 
Informed consent process and procedures
Informed consent process and proceduresInformed consent process and procedures
Informed consent process and proceduresSiddu K M
 
DECLARATION OF HELSINKI
DECLARATION OF HELSINKI DECLARATION OF HELSINKI
DECLARATION OF HELSINKI ClinosolIndia
 
Ethical Issues in Human Subjects Research - Department of Supportive Care
Ethical Issues in Human Subjects Research -  Department of Supportive CareEthical Issues in Human Subjects Research -  Department of Supportive Care
Ethical Issues in Human Subjects Research - Department of Supportive CareGlobal Institute GIPPEC
 
It is time to make a move new
It is time to make a move newIt is time to make a move new
It is time to make a move newAcri India
 
Ethical Considerations In Clinical Trials
Ethical  Considerations In  Clinical  TrialsEthical  Considerations In  Clinical  Trials
Ethical Considerations In Clinical Trialskrathishbopanna
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALMOHAMMED FAHEEM KHAN
 
ICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptxICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptxyogesh532361
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.Audumbar Mali
 
Esssential documnets in clinical trial
Esssential documnets in clinical trialEsssential documnets in clinical trial
Esssential documnets in clinical trialvidit jain
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declarationSimran Narang
 
5.Informed consent process and procedures.pptx
5.Informed consent process and procedures.pptx5.Informed consent process and procedures.pptx
5.Informed consent process and procedures.pptxbrahmaiahmph
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsDRx Tejas Kanhed
 
institutional review board and independent ethics committee
institutional review board and independent ethics committeeinstitutional review board and independent ethics committee
institutional review board and independent ethics committeeMOHAMMAD ASIM
 

Similar to REGULATORY AFFAIR Involve Informed Concent Process and Procedure.pptx (20)

Ethical guideline in nursing research
Ethical guideline in nursing researchEthical guideline in nursing research
Ethical guideline in nursing research
 
informed consent process and procedure .pptx
informed consent process and procedure .pptxinformed consent process and procedure .pptx
informed consent process and procedure .pptx
 
Informed consent process and procedures
Informed consent process and proceduresInformed consent process and procedures
Informed consent process and procedures
 
DECLARATION OF HELSINKI
DECLARATION OF HELSINKI DECLARATION OF HELSINKI
DECLARATION OF HELSINKI
 
Ethical Issues in Human Subjects Research - Department of Supportive Care
Ethical Issues in Human Subjects Research -  Department of Supportive CareEthical Issues in Human Subjects Research -  Department of Supportive Care
Ethical Issues in Human Subjects Research - Department of Supportive Care
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
It is time to make a move new
It is time to make a move newIt is time to make a move new
It is time to make a move new
 
Ethical Considerations In Clinical Trials
Ethical  Considerations In  Clinical  TrialsEthical  Considerations In  Clinical  Trials
Ethical Considerations In Clinical Trials
 
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIALICH GCP GUIDELINES FOR CONDUCT OF TRIAL
ICH GCP GUIDELINES FOR CONDUCT OF TRIAL
 
ICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptxICH GCP by Yogesh Yadav.pptx
ICH GCP by Yogesh Yadav.pptx
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Clinical research
Clinical researchClinical research
Clinical research
 
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.
 
Esssential documnets in clinical trial
Esssential documnets in clinical trialEsssential documnets in clinical trial
Esssential documnets in clinical trial
 
Helsinki declaration
Helsinki declarationHelsinki declaration
Helsinki declaration
 
5.Informed consent process and procedures.pptx
5.Informed consent process and procedures.pptx5.Informed consent process and procedures.pptx
5.Informed consent process and procedures.pptx
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
 
institutional review board and independent ethics committee
institutional review board and independent ethics committeeinstitutional review board and independent ethics committee
institutional review board and independent ethics committee
 
ICH GCP
ICH GCPICH GCP
ICH GCP
 
ich gcp
ich gcpich gcp
ich gcp
 

More from RAHUL PAL

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfRAHUL PAL
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfRAHUL PAL
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfRAHUL PAL
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxRAHUL PAL
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...RAHUL PAL
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfRAHUL PAL
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...RAHUL PAL
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...RAHUL PAL
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...RAHUL PAL
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfRAHUL PAL
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptRAHUL PAL
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptRAHUL PAL
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxRAHUL PAL
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)RAHUL PAL
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...RAHUL PAL
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...RAHUL PAL
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...RAHUL PAL
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...RAHUL PAL
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptxRAHUL PAL
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...RAHUL PAL
 

More from RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxsocialsciencegdgrohi
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 

Recently uploaded (20)

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptxHistory Class XII Ch. 3 Kinship, Caste and Class (1).pptx
History Class XII Ch. 3 Kinship, Caste and Class (1).pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 

REGULATORY AFFAIR Involve Informed Concent Process and Procedure.pptx

  • 1. REGULATORY AFFAIR Submitted By: Prachi Pandey, Rahul Pal Department of Pharmaceuitcs, NIMS Institute of Pharmacy, NIMS University Jhaipur, Rajasthan India. 1st Year, Ist Sem.
  • 2. CONTENTS  Definition  History  Informed Consent Guidelines  The Process of Consent  The Plan of Consent Process  Element of ICF  Components of ICF
  • 3.  A process by which a subject voluntarily confirms his or her willingness to participate in a particular trail, after having been informed of all aspects of the trail that are relevant to the subject’s decision to participate  Inform consent is documented by means of a written, signed and dated informed consent form.  The goal of the informed consent process is to provide people with sufficient information so that they can make informed choices about whether to begin or continue participation in clinical research.
  • 4.
  • 5. Declaration of helsinki  The World Medical Association (WMA) has developed the Declaration of Helsinki as a statement of ethical principles for medical research involving human subjects, including research on identifiable human material and data.
  • 6. Informed consent guidelines  ICMR (Indian Council of Medical Research) “Ethical Guidelines for Biomedical Research on Human use” Published in 2000 and revised in 2006  ICH ICH Guidelines E6 section 4.8 under GCP (Good Clinical Practice)
  • 7. Information provision and sharing by research team Discussion and interaction between research and potential participation True understanding Acceptance or rejection of participant Agreement to participate Follow up End of agreement
  • 8. The Process of Consent Continue Continue the process of consent throughout the study. Ensure Ensure the subject or LAR has sufficient understanding. Ensure Ensure that the subject or Legally Authorized Representative is competent. Include Include family members in the process as warranted. Involve Involve multiple health care personnel as necessary. Choose Choose the right environment and location to obtain consent.
  • 9. Subject or Legally Acceptable Representative (LAR) Person conducting review of consent Impartial witness
  • 10. Elements of Informed Consent Form 1. Essential element:  Purpose  Risks  Benefits  Confidentiality  Compensation  Contact information  Voluntary participation
  • 11. Elements of ICF Statement that will be told of new findings. Approximate number of subjects in study Statement that there may be risks which are unforeseeable. Additional costs to subjects. Withdrawal criteria Additional elements
  • 12. Components of ICF (According to ICMR guidelines, 2006)  Important Information about the Research Study.  What is the study about and why are we doing it?  Benefits of taking part in the study.  Possible risks that might result from being in the study.  Certificate of Confidentiality  What will happen to the information collected after study period is over.  Compensation for being part of the study  Possible expenditure to a subject to be part of study.
  • 13.  Who can profit from study results.  Choices to a subject if they don’t wish to take part in the study.  Voluntariness  Contact information of subject  Contact information of study team.  Consent : Name , Signature and Date  Parent or LAR : Name , Signature and Date